April 2014 FDA Recall Liothyronine Sodium by Sigmapharm Laboratories Llc
D-1344-2014 - Cross Contamination with Other Products

This Class II drug recall was voluntarily initiated by Sigmapharm Laboratories Llc on April 22, 2014 for the product Liothyronine Sodium. The FDA reported the reason for recall as cross contamination with other products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1344-2014

Reason for Recall
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Initiated
04-22-2014
Reported
05-28-2014
Quantity
43,007 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SigmaPharm Laboratories LLC
Nationwide and Puerto Rico
Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.

Batch or Lot Expiration Information

Lot# s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015